Literature DB >> 29297491

High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate.

Ming Zhou1.   

Abstract

Many prostate lesions have 'large gland' morphology with gland size similar to or larger than benign glands, complex glandular architecture including papillary, cribriform, and solid, and significant cytological atypia in glandular epithelium with nucleomegaly, prominent nucleoli, or anisonucleosis. The most common and clinically important lesions with 'large gland' morphology include high-grade prostatic intraepithelial neoplasia (HGPIN), PIN-like carcinoma, ductal adenocarcinoma, and intraductal carcinoma. These lesions have diverse clinical significance and management implications. HGPIN refers to proliferation of glandular epithelium that displays severe cytological atypia within the confines of prostatic ducts and acini. A HGPIN diagnosis in biopsies connotes ~25% risk of detection of cancer in repeat biopsies. It has been accepted as the main precursor lesion to invasive carcinoma. PIN-like carcinoma is a variant of acinar carcinoma that is morphologically reminiscent of HGPIN and is composed of large cancer glands lined with pseudostratified epithelium. Its clinical outcome is similar to that of usual acinar carcinomas and is graded as Gleason score 3+3=6. Ductal adenocarcinoma comprises large glands lined with tall columnar and pseudostratified epithelium. It is more aggressive than acinar carcinomas and is associated with higher stage disease and greater risk of PSA recurrence and mortality. Intraductal carcinoma is an intraglandular/ductal neoplastic proliferation of glandular epithelial cells that results in marked expansion of glandular architecture and nuclear atypia that often exceeds that in invasive carcinomas. In majority of cases, it is thought to represent retrograde extension of invasive carcinoma into pre-existing ducts and acini. Rarely it may represent a peculiar form of carcinoma with predilection for intraductal location. It is considered an adverse pathological feature and is seen almost always in high-grade and volume carcinoma and harbingers worse clinical outcomes. This article reviews 'new' information on the clinical and pathological features of HGPIN, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma, and focuses morphological features that aid the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29297491     DOI: 10.1038/modpathol.2017.138

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

Review 1.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

2.  Endoscopic features of esophageal high-grade intraepithelial neoplasia dominated by cytological atypia.

Authors:  Liang Wang; Nan Dai; Dingrong Chen; Airui Jiang; Guobin Liao; Chaoqiang Fan; Xin Yang; Xue Peng; Xubiao Nie; Hui Lin; En Liu; Xi Liu; Xinwei Diao; Jianying Bai
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 6.166

Review 3.  Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.

Authors:  Maria Destouni; Andreas C Lazaris; Vasiliki Tzelepi
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

Review 4.  Optimizing the diagnosis and management of ductal prostate cancer.

Authors:  Weranja Ranasinghe; Daniel D Shapiro; Miao Zhang; Tharakeswara Bathala; Nora Navone; Timothy C Thompson; Bradley Broom; Ana Aparicio; Shi-Ming Tu; Chad Tang; John W Davis; Louis Pisters; Brian F Chapin
Journal:  Nat Rev Urol       Date:  2021-04-06       Impact factor: 14.432

5.  Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component.

Authors:  Simone de Brot; Jennifer Lothion-Roy; Llorenç Grau-Roma; Emily White; Franco Guscetti; Mark A Rubin; Nigel P Mongan
Journal:  Vet Comp Oncol       Date:  2021-05-18       Impact factor: 2.385

6.  Three-dimensional architecture of common benign and precancerous prostate epithelial lesions.

Authors:  Esther I Verhoef; Wiggert A van Cappellen; Johan A Slotman; Gert-Jan Kremers; Patricia C Ewing-Graham; Adriaan B Houtsmuller; Martin E van Royen; Geert J L H van Leenders
Journal:  Histopathology       Date:  2019-04-21       Impact factor: 5.087

7.  First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion.

Authors:  Kazunori Shojo; Takeo Kosaka; Kohei Nakamura; Hiroshi Hongo; Hiroaki Kobayashi; Shuji Mikami; Hiroshi Nishihara; Mototsugu Oya
Journal:  IJU Case Rep       Date:  2021-03-17

8.  Clinicopathological Analysis of the ISUP Grade Group And Other Parameters in Prostate Cancer: Elucidation of Mutual Impact of the Various Parameters.

Authors:  Yoichiro Okubo; Shinya Sato; Kimito Osaka; Yayoi Yamamoto; Takahisa Suzuki; Arika Ida; Emi Yoshioka; Masaki Suzuki; Kota Washimi; Tomoyuki Yokose; Takeshi Kishida; Yohei Miyagi
Journal:  Front Oncol       Date:  2021-07-28       Impact factor: 6.244

9.  Tailored for Real-World: A Whole Slide Image Classification System Validated on Uncurated Multi-Site Data Emulating the Prospective Pathology Workload.

Authors:  Julianna D Ianni; Rajath E Soans; Sivaramakrishnan Sankarapandian; Ramachandra Vikas Chamarthi; Devi Ayyagari; Thomas G Olsen; Michael J Bonham; Coleman C Stavish; Kiran Motaparthi; Clay J Cockerell; Theresa A Feeser; Jason B Lee
Journal:  Sci Rep       Date:  2020-02-21       Impact factor: 4.379

10.  Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate.

Authors:  Mame-Kany Diop; Roula Albadine; André Kougioumoutzakis; Nathalie Delvoye; Hélène Hovington; Alain Bergeron; Yves Fradet; Fred Saad; Dominique Trudel
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.